and indicates noncompliance
Precision Biomarker and Genetic Context for GLP-1 Responsiveness While a prescription requires standard medical evaluation, emerging science suggests that biomarker and genetic factors may contextualize individual GLP-1 response
doi: 10.3389/fphar.2023.1122632 Received 13 December 2022 Accepted 13 March 2023 Published 27 March 2023 Volume 14 - 2023 Edited by Enrico Sangiovanni, University of Milan, Italy Reviewed by Ayaz Shahid, Western University of Health Sciences, United States Andres A
In ALS, pathological intronic hexanucleotide GGGGCC expansions in the C9orf72 gene are thought to contribute to neurodegeneration by multiple mechanisms, including toxic cytoplasmic dipeptide repeat protein aggregates, toxic RNA gain-of-function, or loss of function due to haploinsufficiency [20, 21]
Spermatozoa have the highest selenium content in mammalian tissues, and the need for selenium increases at the onset of spermatogenesis (Wang et al., 2021)
New data for alcohol and nicotine use disorders are positive, still emerging, and there is also hope about GLP treatment for cannabis use disorder (CUD), which has accelerated quickly